WO2022160018 - ANTIVIRAL NASAL SPRAY
National phase entry:
Publication Number
WO/2022/160018
Publication Date
04.08.2022
International Application No.
PCT/AU2022/050103
International Filing Date
15.02.2022
Title **
[English]
ANTIVIRAL NASAL SPRAY
[French]
PULVÉRISATION NASALE ANTIVIRALE
Applicants **
MEYERS, Alicia, Gemma, Eileen
MCCAFFREY, Stephen, Mark
HAGGART, Ethan Tobias Grey
Inventors
MEYERS, Alicia, Gemma, Eileen
Priority Data
2022200728
03.02.2022
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1954 | |
| EPO | Filing, Examination, Granting | 8705 | |
| Japan | Filing, Examination, Granting | 1835 | |
| South Korea | Filing, Examination, Granting | 1394 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
19,228
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention is directed to a nasal spray formulation comprising bee pollen and/or propolis together with Manuka honey UMF 20+, which formulation can be used for preventing coronavirus infection.[French]
L'invention concerne une formulation de pulvérisation nasale comprenant du pollen et/ou de la propolis d'abeille associé à du miel Manuka UMF 20+, ladite formulation pouvant être utilisée pour prévenir une infection à coronavirus.